Headlines / News Show Archive 
Summit Session 1A: Top Black Doctors Provide Perspectives on COVID-19 and The Prostate Cancer Disparity

Session 1 Part A: PHEN's "16th Annual African American Prostate Cancer Disparity Summit" features Dr. Edith Mitchell as co-moderator, Dr. Durado Brooks, Dr. J. Jacques Carter, Dr. Pamela Coleman, Dr. Curtis Pettaway, Dr. Walter Rayford, and Dr. Mack Roach.
Summit Session 1B: Prostate Cancer Survivors and Advocates Speak on COVID-19 Impact

Survivors and advocates provide their perspectives following the medical panel as part of session 1B of PHEN's 16th Annual Summit.
New Treatments and Clinical Trials: The Use of Genetic Information to Attack Cancers

Dr. Keith Crawford, PHEN Director of Clinical Trials and Patient Education
Genetic Testing Can Impact Your Prostate Cancer Journey

Todd Cohen, MD, Vice President of Medical Affairs and Medical Director of Urology at Myriad Genetics
Why African American Prostate Cancer Is a Crisis Within the COVID-19 Crisis
By: Thomas A. Farrington, PHEN President and Founder
featured in June issue of "Future of Personal Health" as part of the "Prostate and Urological Health Campaign."
Celebrating 20 Years of Prostate Cancer Survivorship on July 4th, 2020

On July 4th, 2000 my wife Juarez and I boarded a plane in Boston, MA, launching our prostate cancer journey and changing our lives forever. My father's life was taken by prostate cancer on Christmas Eve 1999 at age 78. Three months later...

PSA Screening for Prostate Cancer More Beneficial Than Previously Recognized
By: Jody A. Chernow; Renal and Urology News; June 25, 2020
Inherited mutation linked to higher prostate cancer risk in African American families

A new study
 identifies an inherited genetic variant associated with higher risk of prostate 
 in men of African descent.
Recorded Webinar: Accelerating Efforts to Address the Prostate Cancer Racial Disparity

PHEN and its church partners discuss and outline strategies to enhance and accelerate efforts at the community level to address the prostate cancer disparity.
Dramatic drop in cancer diagnoses amid COVID pandemic is cause for concern, doctors say

Experts fear concerns over coronavirus has led to far too few screenings.

By Dr. Mark Abdelmalek and Lucien bruggeman

Recorded Webinar: How COVID-19 Is Impacting Prostate Cancer Early Detection and Treatment

A recording of PHEN's May 13th live webinar featuring prostate cancer medical specialists.
Cancer patients face high mortality from COVID-19

People with cancer who develop COVID-19 are much more likely to die from the disease than those without cancer
Special Prayers and Inspirational Messages For Cancer Survivors In The COVID-19 Storm

Patients and Caregivers Connecting During The COVID-19 Crisis

PHEN survey results of patients and caregivers during the COVID-19 pandemic
The Coronavirus and Cancer Patients - A Special Video Presentation

PHEN's Director of Clinical Trials and Patient Education, Dr. Keith Crawford, outlines the increased risks that the coronavirus poses to cancer patients. An in-depth review for prostate cancer patients.
Daddy's Boys Stage Play Performances Postponed Due to COVID - 19

Updated information about the new scheduling of the Daddy's Boys stage play performances due to COVID - 19.

Regular exercise is important for good bone health.

It increases bone mass, makes bone stronger, maintains and improves muscle strength, coordination and balance. Thus reducing the risk of fractures from falls. 
A Small Number Of Men With Prostate Cancer Are 'Super Responders' to Immunotheraphy
Results from a new clinical trial have shown that some men with advanced prostate cancer can live for at least two more years on immunotherapy after exhausting all other treatment options...
Psychosocial Concerns Common After Prostate Cancer Treatment
Psychosocial problems that adversely affect quality of life are common among men after receiving treatment for prostate cancer, and they need help....
Men Over 40 With BRCA2 Mutations Must Get Prostate Cancer Screening, Experts Say
Researchers have called for immediate action to recommend screening for prostate cancer for men with BRCA2 mutations over the age of 40. 
Increasing Diversity in Clinical Trials

Clinical trials lead to the approval of new drugs.  A recent article reported that black enrollment is extremely low; limiting our understanding of how these drugs effect blacks...
One Two Punch could slow the spread of cancer

There is no one pathway, which controls prostate cancer growth, more clinical trials are being designed using more than one drug. This ONE TWO punch design could slow the spread of cancer. 
Guideline Released on Addressing Osteoporosis Risk With Non-metastatic Cancer

Cancer and therapies used to treat it may raise a patient’s risk of osteoporosis.
Enrollment Completed for Phase 3 Trial Testing Provenge in Prostate Cancer Patients on Active Surveillance
Dendreon Pharmaceuticals has completed patient enrollment ahead of schedule in an ongoing Phase 3 trial
PHEN “Daddy’s Boys” Performance a Hit in Boston
Boston was the 14th city where the play has been performed and the audience numbered 500.
PHEN Hosts Workshop In Boston
PHEN hosted an educational workshop. Dr. J. Jacques Carter, Beth Israel Deaconess Hospital and Dr. Jairam Eswara from St. Elizabeth’s Medical Center were the presenters
Daddy's Boys Play Highlights Black Men and Prostate Cancer
PHEN President Thomas Farrington discusses how the play addresses the prostate cancer crisis among black men on Boston Network News Television (BNNT)
Congressman Gregory W. Meeks Presents at African-American Prostate Cancer Disparity Summit

Congressman Gregory W. Meeks presents at PHEN's Fifteenth Annual African-American Prostate Cancer Disparity Summit.

The African American Disparity - Biology or Access?

Daniel George MD (Duke) and Brandon Mahal MD (Dana-Farber) speak on unequal access to treatment and biological/genetic differences. 
Increasing African American Participation in Clinical Trials

Keith Crawford MD PhD (PHEN) and panelists discuss strategies towards increasing diversity in clinical trials enrollment.
New Developments in Prostate Cancer Treatment

Richard Lee MD PhD (Mass General) presents an update of the prostate cancer treatment paradigm with
An Initiative to Address Veterans Needs

Mr. Arnold J. Merriweather, a Vietnam Veteran, speaks on his efforts in Jacksonville, FL with veterans in the fight against prostate cancer. 
Erleada Approved for Metastatic Castration-Sensitive Prostate Cancer

The FDA has approved the supplemental New Drug Application for Erleada (apalutamide; Janssen) for the treatment of patients with Metastatic Castration-Sensitive Prostate Cancer.
PHEN Presents "Daddy's Boys" A Broadway-Style Stage Play at the John Hancock Hall Boston, MA

On Saturday, October 19, 2019, at 6 PM, PHEN is bringing "Daddy's Boys" to Boston. Get tickets here
Friday, Sept 13 Summit Program

The summit convened prostate cancer survivors and medical, community, industry and policy leaders to address issues towards eliminating the prostate cancer racial disparity.

Thursday, September 12 Summit Program

The summit convened prostate cancer survivors and medical, community, industry and policy leaders to address issues towards eliminating the prostate cancer racial disparity.

Body fat may predict aggressive prostate cancer

Excess weight not only raises your risk of prostate cancer, it can also mean more aggressive and fatal cancer.

Skeletal-Related Events Common After CRPC Development

Men with prostate cancer
have a 40% cumulative incidence of first skeletal-related events (SREs) following development of castration-resistant disease
Quality of Life Outcomes Comparable Regardless of Treatment With HRT or CRT for Low-Risk Prostate Cancer

Hypofractionated radiotherapy is noninferior to conventional radiotherapy for quality-of-life outcomes among men with low-risk prostate tumors.

Are fighter pilots at greater risk for prostate cancer? The Air Force is now asking

The Air Force has begun to look at whether there's increased risk for prostate cancer among its fighter pilots. A new investigation by McClatchy shows just how serious the problem may be.
August 14th Webcast: Prostate Cancer and the Impact on Bone Health

Guest Speaker: Keith Crawford, MD, PhD
Director of Clinical Trials and Patient Education

Jesse's Story

Jesse Penn's story highlights the importance of prostate cancer survivors knowing about their bone health.
Clinical Trials: Another Treatment Option for Patients - Thomas Farrington Interview with URO Today

PHEN President Tom Farrington talks to Dr. Alicia Morgans, Assoc. Professor of Medicine at the Northwestern University Feinberg School of Medicine on how to engage best with patients.  
FDA approves Bayer’s Nubeqa®, a new treatment for men with non-metastatic castration-resistant prostate cancer

Nubeqa was approved under the FDA’s Priority Review designation; approval granted three months ahead of target FDA action date.

Highly Successful Daddy's Boys Stage Play in New Orleans, LA

PHEN presented the
“Daddy’s Boys" stage play on June 29th at the Southern University of New Orleans.
New BRCA Blue campaign educates about the link between BRCA gene mutations and cancer

Prostate Conditions Education Council in partnership with other leading prostate cancer advocacy organizations, announces the launch of the BRCA Blue Campaign.

Prostate Cancer ADT Raises Dementia Risk, Study Finds

Men who receive androgen deprivation therapy for prostate cancer are at increased risk for dementia, according to a new study.

Big Jump in Active Surveillance for Low-Risk Prostate Cancer

New findings show a dramatic increase in the number of men taking a conservative approach to low-risk prostate cancer.
Black Race Not Associated With Higher Prostate Cancer Death Risk

Black men with nonmetastatic prostate cancer do not appear to have worse survival than their white counterparts.

AME Church Bishops Partner With PHEN On Prostate Cancer Education

Bishops Harry Seawright and Adam J. Richardson, Jr. joined efforts with PHEN to expand prostate cancer outreach within their districts
Churches Are Supporting PHEN Efforts by Hosting Daddy's Boys Stage Play

Churches across the country are supporting PHEN efforts to raise prostate cancer education and awareness by hosting the Daddy's Boys stage play performances within their communities. 
Bethel AME Church Los Angeles to Host 6th Consecutive Symposium

Bethel AME Los Angeles continues its strong commitment towards education and awareness under the leadership of pastor Rev. Dr. Calloway who is also a member of the PHEN Network.
Biomarker Testing Needed Before African American Patients Choose Active Surveillance

Thomas Farrington, PHEN President, outlines why genomic biomarker testing is needed by African American patients before they choose active surveillance....
May 8th Webcast: Biomarker Testing Needed Before Making Treatment Decisions

Guest Speaker: Dr. Todd D. Cohen, Medical Director at Myriad Genetics

Evidence Supports Stereotactic Body Radiotherapy as a Standard of Care for Localized PC

Evidence supports stereotactic body radiotherapy — a highly precise radiation therapy delivered in shorter periods of time — as a standard treatment for people with localized prostate cancer.

Innovative Format is Key to Reaching & Educating African Americans About Prostate Cancer

The “Daddy’s Boys” stage play, presented on tour by PHEN, draws 1,000+ national attendees per performance.

Prostate cancer diagnoses, deaths decreasing worldwide

Prostate caner, one of the deadliest forms of cancer for men in the United States and worldwide, is on the decline.

African American Men Respond Better to Treatments For Advanced Prostate Cancer in Clinical Trials

New research shows that African American men who receive treatments for late-stage prostate cancer can live at least as long, or even longer than their Caucasian counterparts.

Better Survival for African-Americans with Metastatic Prostate Cancer

African-American men with metastatic castration-resistant prostate cancer and no chemotherapy lived significantly longer than white men when treated with newer hormonal therapies.

Your Risk Of Prostate Cancer Just Dropped Precipitously, Here's Why

Most men diagnosed with Prostate Cancer don't die of the disease. 

Certain Factors Impact Treatment Selection in Advanced Prostate Cancer

A patient's race, income level, geographic area of residence, and whether mangement is conducted may influence the type of treatment administered.

PSA Testing Cuts Deaths, Shows Value of Long-Term Screening

A blood test measuring the levels of PSA cuts deaths from the disease by nearly 30%.

Xtandi Delays Disease Progression, Death in Metastatic Hormone-Sensitive PC Patients, Trial Shows

Xtandi Delays Disease Progression, Death in Metastatic Hormone-Sensitive PC Patients.
Newer mCRPC Drugs Led to Longer Survival in African American Patients

Newer mCRPC Drugs Led to Longer Survival in African American Patients.

More Men With Low-Risk Prostate Cancer Are Forgoing Treatment

More men with low-risk prostate cancer are forgoing treatment for active surveillance.

Comorbidities Adversely Linked to Cancer Trial Participation

For cancer patients, the presence of comorbidities is adversely linked to trial discussions, trial offers, and trial participation.
Finasteride shows long-term safety, efficacy for prostate cancer prevention

Finasteride safely and effectively prevented prostate cancer, despite previous findings that suggested the drug increased the risk for high-grade disease.
Black men with low-risk prostate cancer have higher mortality rate

Black men diagnosed with low-risk prostate cancer may have more aggressive forms of the disease than nonblack men with the same diagnosis.
January Webcast: Clifford D Gluck, MD, FACS

Dr. Clifford Gluck presents webinar on the Treatmen of Stress Urinary Incontinence and Rejuvenation of Erectile Function.
PHEN Introduces Find Your Trial (FYT) Search Tool

Dr. Arash Eshraghi presents the FYT
 search tool to help those diagnosed with prostate cancer find clinical trials based on their prostate cancer stage
PHEN Kicks-Off 2019 Tour to Sold Out Shows

PHEN brought the acclaimed Broadway-style stage play "Daddy's Boys" to Riverside EpiCenter in Atlanta GA on Saturday, January 12.
Daddy's Boys Feedback and Comments

Read what audience members feedback and comments were from the Riverside Epicenter in Atlanta GA on January 12 said. 
Dec 12th Webcast: Celebrating the Blessings of Church Partnerships

Pressentations by Rev. Adrian Backus (PHEN) and Rev. Joseph Deck (Reid Temple AME Church, MD)
November Webcast: Understanding Progression of Prostate Cancer

David Russell, MD from Pfizer US Medical Affairs
Gleason 6 Prostate Cancer More Lethal in Black Men

Black men are more likely than white men to die from Gleason 6 (low-risk) prostate cancer, according to investigators.

PHEN Receives Healthy Churches 2020 Best Practices Award

PHEN Honored by The Balm in Gilead with Healthy Churches 2020 Best Practice Award
Prostate Cancer Linked to Greater Fat, Fatty Acid Intake

Greater intake of some fatty acids is associated with a higher risk of prostate cancer 
Barriers to Prostate Cancer Research in Black Men Identified

Investigators identified genomic testing barriers including a lack of terminology understanding, health care system mistrust, and other factors.

Clinical Trials e-Newsletter October

RESPOND Study, Darolutamide and Rubraca
Dr. Artie Shelton Speaks to Men and Women Groups in Alexandria, VA
Dr. Artie Shelton spoke at the Bethlehem Baptist Church Annual Men's and Women's Day in Alexandria, VA.
October Webcast: Advances in Radiation Therapy for Prostate Cancer

Guest Presenter: Peter F Orio III, DO, MS
Boosting African American participation in prostate cancer clinical trials
Article featured in ChangeTogether.com highlights PHEN efforts to increase African American participation in prostate cancer clinical trials.
PHEN successfully Launches Social Media Initiative at Annual Summit

More than 8,000 viewers tuned into the 14th Annual Summit as PHEN launched new Social Media Initiative with church partners.

Clinical Trials e-Newsletter for July

Clinical Trials For New Classes of Drugs in the Fight Against Prostate Cancer
Study On Aggressive Prostate Cancer In African-American Men Launched
A coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men
PHEN’s 10th Annual Father’s Day Rally Grows and Expands National Outreach

PHEN is proud to present the "10th Annual Father's Day Rally Against Prostate Cancer" on Father’s Day, June 17th, 2018..

The Connection Between Genetics and Prostate Cancer Focusing On BRACA Gene Mutations
June 13th webcast presentation by Karen Copeland, MS, MBA, Certified Genetic Counselor with Myriad Genetics Laboratory, Urology Department.
Blacks With Advanced Prostate Cancer May Fare Better Than Whites
"study underscores the importance of increasing the participation of racial minorities in clinical trials..."
PHEN Entertains & Educates with “Daddy’s Boys” Stage Play

PHEN presented “Daddy’s Boys" stage play on May 12 at Reid Temple AME Church in Glenn Dale, MD before an audience 1,000 plus.  It was exciting & a highly successful community based prostate cancer education & awareness event.

Diet, Exercise With Behavioral Counseling Can Reduce ADT Side Effects

A personalized exercise and diet intervention can lead to clinical improvement.

BRCA Mutations Up Risk for Prostate Cancer

Males with BRCA mutations have increased incidence of malignant disease.

Daddy’s Boys – a new play tackling prostate cancer disparity in African-American men

Astellas Pharma highlights PHEN's "infotainment" initiative in its Change Together online portal
Prostate Cancer: ADT Plus Docetaxel May Improve 12-Month Quality of Life

Androgen-deprivation therapy (ADT) with docetaxel may improve quality of life (QoL) at 12 months among patients with metastatic hormone-sensitive prostate cancer

Xtandi Reduces Risk of Metastasis in Castration-resistant Prostate Cancer

Treatment with Xtandi (enzalutamide) reduced the risk of metastasis or death in castration-resistant prostate cancer (CRPC) patients whose cancer has not yet spread beyond the prostate.

Patients should "Ask-In" on clinical trials participation

African American participation in prostate cancer clinical trials must move from 3-5% range to 10-12% range to determine the effectiveness of new treatments.

Two new treatments have been found for prostate cancer patients who previously had no effective treatment options

Clinical trials have found that Enzalutamide and Apalutamide are both able to significantly delay prostate cancer progression in men with non-metastatic castration-resistant prostate cancer. 
Survivor Network Spotlight - Raymond Fuller, Jr.

During a regular check-up in 2008, Ray Fuller was diagnosed with prostate cancer.  There was no family history of the disease, he said, it “just popped up.”

How dietary fat helps prostate cancer to spread

New research demonstrates how the fat contained within the Western diet, in combination with genetic factors, can cause prostate cancer tumors to spread.

Survivor Network Spotlight - Robbie Robinson

There is no good time to get such news, but it was particularly jarring when Robbie Robinson was diagnosed with prostate cancer in 2002.  

Turmeric, red grape, and apple compounds 'starve' prostate cancer cells

According to a new study, turmeric, apples and grapes could hold key to preventing and treating one of the most common cancers.

Mediterranean Diet Best for Lowering Aggressive Prostate Cancer Risk

Simply consuming fruits, vegetables, and whole grains might not sufficiently protect men from aggressive prostate cancer. (PCa)

Smaller Difference in Prostate Cancer Death Risk Found

New research shows that prostate cancer (PCa) mortality risk is lower after radical prostatectomy compared with radiotherapy, but the difference in risk is much smaller than found in previous studies.

Blood Test Performs as Well as Tissue Biopsy in Characterizing Prostate Cancer, Study Finds

A blood test may one day replace tumor tissue sampling for patients with prostate cancer.

Shorter but Higher-dose Radiation Course Cuts Risk of Prostate Cancer Returning

Delivering radiation in a shorter time frame significantly reduced the chance of prostate cancer returning in men with an intermediate-risk form of the disease, a study found

Xtandi Does Not Increase Seizure Rates in At-Risk Metastatic Prostate Cancer Patients

Safety study into treatment of mCRPC patients with Xtandi found therapy does not increase seizure rates.

Preference for preserving sexual function not strongly reflected in treatment choices

In a survey of nearly 1,200 men who have prostate cancer, more than half indicated that preserving sexual function was "very important" to them.

How African-American Men Can Beat the Odds Against Prostate Cancer

"The incidence of prostate cancer is over 60 percent higher in African-American men compared to white men, and in terms of mortality, it's 150 percent higher," says Thomas Farrington.

Radiotherapy or Prostatectomy?

Quality of Life is better after modern radiotherapy compared with surgery according to recent studies.

Surgery vs Radiation for High-Risk Prostate Cancer

High-risk prostate cancer (PCa) is well defined, but opinions vary on whether radical prostatectomy or radiation therapy is the best treatment approach.

Connecting the dots between weight loss and prostate cancer

U.S. veterans help shed light on link between dropping pounds and slowing progression of the disease

2017 African American Prostate Cancer Disparity Summit Videos

All presentations from PHEN's 2017 Summit program are available via videos...

PHEN President & Founder Received an Award from Congressman Gregory Meeks (NY)

Thomas A. Farrington, was presented with the Congressional Black Caucus Leadership Award by Congressman Gregory Meeks (NY) at PHEN's 13th Annual Summit. 

Common factors that could change your PSA test results

How the test works and why different factors such as prescription medications and infections can change your PSA test results.

SpaceOAR Protects Surrounding Prostate Tissues

Augmenix's SpaceOAR System can effectively protect the rectum of prostate cancer patients undergoing high dose stereotactic body radiation therapy (SBRT).

2017 African American Prostate Cancer Disparity Summit was a success

In September at the 2017 African American Prostate Cancer Disparity Summit, Gary L. Taylor, M.D., the Medical Director for PHEN's Clinical Trials Rally updated everyone on the successful first phase of the Clinical Trials Rally and had several prestigious speakers talk about the importance of continuing the commitment of the Clinical Trials Rally

PHEN Expands National Educational Outreach

With twelve symposiums in nine states completed from April through June, and another 13 scheduled through November, the Prostate Health Education Network (PHEN) is taking its educational efforts to greater heights. 

Our Journey to Establish Prostate SBRT as a Standard of Care

SBRT is a unique modality of radiation treatment. Typically, radiation therapy is delivered in many small doses called fractions (often 40 or more), but studies have been created to explore the possibility of delivering radiation in fewer...

Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men

African American men appear to be more likely to consider economic factors in their decsion-making.

Major League Baseball Goes Blue Blue For Prostate Cancer Awareness

Major league teams participated on Father's Day awareness effort.
PHEN Network Member Arnold Merriweather Father's Day Interview

Arnold J. Merriweather president of the  Black Male Prostate Cancer Coalition in Jacksonville, Fl., and PHEN Network member speaks about the importance of faith in his prostate cancer journey. 

June Webcast - Prostate Cancer: Breaking The Silence

A panel discussion with survivors, wives and church leaders.

(Use Internet Explorer, Firefox or Safari browsers, Do NOT use Google Chrome browsers)

BBN News Interview: Thomas A Farrington Discuss PHEN 2017 Symposium and Father's Day Rally
Emotionally Distressed Prostate Cancer Patients May Ask for Overly Aggressive Therapy
Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer
PSA Screening Rates Level Off in United States

The USPSTF recommended against PSA testing for men of all ages in 2012.

African Americans at Higher Risk of Metastatic Prostate Cancer

African American men have a higher incidence of preclinical prostate cancer and are more likely to progress to metastatic disease.

Prostate Cancer?s Aggressive Nature in Black Americans Suggests Need for More Personalized Screening

The higher rates at which black men are dying of prostate cancer may be linked to faster disease progression, according to a new study. 

No Menthol Sunday

Join us on May 28, 2017 in this faith movement for health

Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer

Active surveillance is an alternative strategy to undergoing surgery or radiation for men with low-grade prostate cancer...

The PHEN Network In Action Spotlight: Bishop Bob Jackson

Bishop Bob Jackson is a prostate cancer survivor and
senior pastor at "Act Full Gospel church of God In Christ" in Oakland, CA

Bishop Jackson's Ongoing Impact On Prostate Health In Oakland
By: Michael Shaw, Director of the Alameda County, CA (Oakland) Office of Urban Male Health
Meet Three Women Who Transformed Their Husbands Prostate Cancer Fight
Women play an important role when their loved ones are faced with prostate cancer. A Media Planet article distributed in the September 2nd USA Today newspaper.
PSA Screening for Prostate Cancer More Beneficial Than Previously Recognized
By: Jody A. Charnow; Renal and Urology News; June 25, 2020
How nerves fuel prostate cancer growth

Certain nerves support the growth of prostate cancer via a tumor vessel proliferating "switch," according to a study by researchers from the Albert Einstein College of Medicine. This finding could potentially lead to a new strategy for treating prostate cancer.

Symposium in Miami on Saturday, October 28

PHEN will host a prostate health educational symposium at Morning Star Baptist Church beginning at 9 am. Free prostate cancer screening and includes lunch.

Task Force Comments
PHEN Comments on USPSTF PSA Screening Recommendation
June 2017 Webcast PPT

PHEN,Inc. © 2020 All rights reserved